EBV EA (Early Antigen) IgM ELISA Kit

  • Created on the 18 July, 2017.


Human EBV EA IgM ELISA kit is a procedure for analysing in-vitro quantitative levels of human IgM antibodies to the Epstein–Barr virus early antigen (EBV EA) using samples of plasma or serum. This EBV EA-IgM ELISA kit has a minimum analytical sensitivity limit of 1.1 U/ml.


Epstein–Barr virus (EBV) can also be referred to as human herpesvirus 4 (HHV-4) and it belongs to the family of viruses known as herpes. EBV is responsible for causing infectious mononucleosis, an illness which is associated with sore throat, fever, swollen lymph nodes and sometimes enlarged spleen. This virus is able to spread through many commonly bodily fluids, especially saliva. It is also able to spread through blood and semen, organ transplantations and blood transfusions. A large number of these viral infections have been linked to autoimmune diseases for example Sjögren’s syndrome, multiple sclerosis, dermatomyositis, systemic lupus erythematosus and rheumatoid arthritis. EBV Early antigen (EBV EA) can be associated to a number of different acute phase illness, however, after 3-6 months the levels become undetectable. EBV EA-IgM ELISA kit can be used for analysing many diagnostic applications.


The minimum detection sensitivity level of IgM antibodies directed to Epstein–Barr virus early antigen (EBV EA-IgM) using current human EBV EA IgM ELISA kit was 1.1 U/ml. The dynamic range for this ELISA assay is 1.0 – 200.0 U/ml.


  1. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo. (2004) 18 (2): 101-6. Lerner A.M., et al.
  2. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients. Scand J Rheumatol. (2015) 44 (2): 143-9. Rasmussen N.S., et al.
  3. Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis. J Virol Methods. (1988) 21 (1-4): 133-46. Middeldorp J.M., Herbrink P.
  4. EBV reactivation serological profile in primary Sjögren’s syndrome: an underlying trigger of active articular involvement? Rheumatol Int. (2013) 33 (5): 1149-57. Pasoto S.G., et al.
  5. Antibodies to Epstein-Barr virus-induced early antigens in blood donors. Acta Virol. (1989) 33 (4): 344-8. Wohlrabe P., et al.


  • Full Name: EBV EA (Early Antigen) IgM ELISA Kit
  • Reactivity: Human
  • Sample Type: Plasma, Serum
  • Sensitivity: 1.1 U/ml



Your secretory IgA ELISA kit gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA kit performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA kits from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA kits. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford